 | • レポートコード：MRC2012A6954 • 出版社/出版日：GlobalInfoResearch / 2020年12月24日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、PET用放射性医薬品の世界市場を広く調査・分析し、今後の市場展望をまとめております。PET用放射性医薬品の種類別市場規模（F-18、Ru-82、その他）、用途別市場規模（腫瘍、心臓病、神経、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Cardinal Health Inc. (U.S.)、Nordion, Inc. (Canada)、Lantheus Medical Imaging, Inc. (U.S.)、Mallinckrodt plc (Ireland)、Eczacibasi-Monrol Nuclear Products (Turkey)、GE Healthcare (U.K.)、IBA Molecular Imaging (Belgium)、Bracco Imaging S.p.A (Italy)、Bayer AG (Germany)、Advanced Accelerator Applications S.A. (France)、 ・地域別グローバル市場分析 2015年-2020年 ・PET用放射性医薬品の北米市場（アメリカ、カナダ、メキシコ） ・PET用放射性医薬品のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・PET用放射性医薬品のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・PET用放射性医薬品の南米市場（ブラジル、アルゼンチン） ・PET用放射性医薬品の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：F-18、Ru-82、その他 ・用途別分析：腫瘍、心臓病、神経、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global PET Radiopharmaceuticals market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The PET Radiopharmaceuticals market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
PET Radiopharmaceuticals market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, PET Radiopharmaceuticals market has been segmented into
F-18
Ru-82
Others
By Application, PET Radiopharmaceuticals has been segmented into:
Oncology
Cardiology
Neurology
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global PET Radiopharmaceuticals market presented in the report. This section sheds light on the sales growth of different regional and country-level PET Radiopharmaceuticals markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global PET Radiopharmaceuticals market.
The report offers in-depth assessment of the growth and other aspects of the PET Radiopharmaceuticals market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and PET Radiopharmaceuticals Market Share Analysis
PET Radiopharmaceuticals competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, PET Radiopharmaceuticals sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the PET Radiopharmaceuticals sales, revenue and market share for each player covered in this report.
The major players covered in PET Radiopharmaceuticals are:
Cardinal Health Inc. (U.S.)
Nordion, Inc. (Canada)
Lantheus Medical Imaging, Inc. (U.S.)
Mallinckrodt plc (Ireland)
Eczacibasi-Monrol Nuclear Products (Turkey)
GE Healthcare (U.K.)
IBA Molecular Imaging (Belgium)
Bracco Imaging S.p.A (Italy)
Bayer AG (Germany)
Advanced Accelerator Applications S.A. (France)
Among other players domestic and global, PET Radiopharmaceuticals market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe PET Radiopharmaceuticals product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of PET Radiopharmaceuticals, with price, sales, revenue and global market share of PET Radiopharmaceuticals in 2018 and 2019.
Chapter 3, the PET Radiopharmaceuticals competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the PET Radiopharmaceuticals breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, PET Radiopharmaceuticals market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe PET Radiopharmaceuticals sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 PET Radiopharmaceuticals Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global PET Radiopharmaceuticals Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 F-18
1.2.3 Ru-82
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global PET Radiopharmaceuticals Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Neurology
1.3.5 Others
1.4 Overview of Global PET Radiopharmaceuticals Market
1.4.1 Global PET Radiopharmaceuticals Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Cardinal Health Inc. (U.S.)
2.1.1 Cardinal Health Inc. (U.S.) Details
2.1.2 Cardinal Health Inc. (U.S.) Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Cardinal Health Inc. (U.S.) SWOT Analysis
2.1.4 Cardinal Health Inc. (U.S.) Product and Services
2.1.5 Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Nordion, Inc. (Canada)
2.2.1 Nordion, Inc. (Canada) Details
2.2.2 Nordion, Inc. (Canada) Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Nordion, Inc. (Canada) SWOT Analysis
2.2.4 Nordion, Inc. (Canada) Product and Services
2.2.5 Nordion, Inc. (Canada) PET Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Lantheus Medical Imaging, Inc. (U.S.)
2.3.1 Lantheus Medical Imaging, Inc. (U.S.) Details
2.3.2 Lantheus Medical Imaging, Inc. (U.S.) Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Lantheus Medical Imaging, Inc. (U.S.) SWOT Analysis
2.3.4 Lantheus Medical Imaging, Inc. (U.S.) Product and Services
2.3.5 Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Mallinckrodt plc (Ireland)
2.4.1 Mallinckrodt plc (Ireland) Details
2.4.2 Mallinckrodt plc (Ireland) Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Mallinckrodt plc (Ireland) SWOT Analysis
2.4.4 Mallinckrodt plc (Ireland) Product and Services
2.4.5 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Eczacibasi-Monrol Nuclear Products (Turkey)
2.5.1 Eczacibasi-Monrol Nuclear Products (Turkey) Details
2.5.2 Eczacibasi-Monrol Nuclear Products (Turkey) Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Eczacibasi-Monrol Nuclear Products (Turkey) SWOT Analysis
2.5.4 Eczacibasi-Monrol Nuclear Products (Turkey) Product and Services
2.5.5 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 GE Healthcare (U.K.)
2.6.1 GE Healthcare (U.K.) Details
2.6.2 GE Healthcare (U.K.) Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 GE Healthcare (U.K.) SWOT Analysis
2.6.4 GE Healthcare (U.K.) Product and Services
2.6.5 GE Healthcare (U.K.) PET Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 IBA Molecular Imaging (Belgium)
2.7.1 IBA Molecular Imaging (Belgium) Details
2.7.2 IBA Molecular Imaging (Belgium) Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 IBA Molecular Imaging (Belgium) SWOT Analysis
2.7.4 IBA Molecular Imaging (Belgium) Product and Services
2.7.5 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Bracco Imaging S.p.A (Italy)
2.8.1 Bracco Imaging S.p.A (Italy) Details
2.8.2 Bracco Imaging S.p.A (Italy) Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Bracco Imaging S.p.A (Italy) SWOT Analysis
2.8.4 Bracco Imaging S.p.A (Italy) Product and Services
2.8.5 Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Bayer AG (Germany)
2.9.1 Bayer AG (Germany) Details
2.9.2 Bayer AG (Germany) Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Bayer AG (Germany) SWOT Analysis
2.9.4 Bayer AG (Germany) Product and Services
2.9.5 Bayer AG (Germany) PET Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Advanced Accelerator Applications S.A. (France)
2.10.1 Advanced Accelerator Applications S.A. (France) Details
2.10.2 Advanced Accelerator Applications S.A. (France) Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Advanced Accelerator Applications S.A. (France) SWOT Analysis
2.10.4 Advanced Accelerator Applications S.A. (France) Product and Services
2.10.5 Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global PET Radiopharmaceuticals Sales and Market Share by Manufacturer (2018-2019)
3.2 Global PET Radiopharmaceuticals Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 PET Radiopharmaceuticals Manufacturer Market Share in 2019
3.3.2 Top 6 PET Radiopharmaceuticals Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global PET Radiopharmaceuticals Sales, Revenue and Market Share by Regions
4.1.1 Global PET Radiopharmaceuticals Sales and Market Share by Regions (2015-2020)
4.1.2 Global PET Radiopharmaceuticals Revenue and Market Share by Regions (2015-2020)
4.2 North America PET Radiopharmaceuticals Sales and Growth Rate (2015-2020)
4.3 Europe PET Radiopharmaceuticals Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific PET Radiopharmaceuticals Sales and Growth Rate (2015-2020)
4.5 South America PET Radiopharmaceuticals Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa PET Radiopharmaceuticals Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America PET Radiopharmaceuticals Sales, Revenue and Market Share by Country
5.1.1 North America PET Radiopharmaceuticals Sales and Market Share by Country (2015-2020)
5.1.2 North America PET Radiopharmaceuticals Revenue and Market Share by Country (2015-2020)
5.2 United States PET Radiopharmaceuticals Sales and Growth Rate (2015-2020)
5.3 Canada PET Radiopharmaceuticals Sales and Growth Rate (2015-2020)
5.4 Mexico PET Radiopharmaceuticals Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe PET Radiopharmaceuticals Sales, Revenue and Market Share by Country
6.1.1 Europe PET Radiopharmaceuticals Sales and Market Share by Country (2015-2020)
6.1.2 Europe PET Radiopharmaceuticals Revenue and Market Share by Country (2015-2020)
6.2 Germany PET Radiopharmaceuticals Sales and Growth Rate (2015-2020)
6.3 UK PET Radiopharmaceuticals Sales and Growth Rate (2015-2020)
6.4 France PET Radiopharmaceuticals Sales and Growth Rate (2015-2020)
6.5 Russia PET Radiopharmaceuticals Sales and Growth Rate (2015-2020)
6.6 Italy PET Radiopharmaceuticals Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific PET Radiopharmaceuticals Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific PET Radiopharmaceuticals Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific PET Radiopharmaceuticals Revenue and Market Share by Regions (2015-2020)
7.2 China PET Radiopharmaceuticals Sales and Growth Rate (2015-2020)
7.3 Japan PET Radiopharmaceuticals Sales and Growth Rate (2015-2020)
7.4 Korea PET Radiopharmaceuticals Sales and Growth Rate (2015-2020)
7.5 India PET Radiopharmaceuticals Sales and Growth Rate (2015-2020)
7.6 Southeast Asia PET Radiopharmaceuticals Sales and Growth Rate (2015-2020)
7.7 Australia PET Radiopharmaceuticals Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America PET Radiopharmaceuticals Sales, Revenue and Market Share by Country
8.1.1 South America PET Radiopharmaceuticals Sales and Market Share by Country (2015-2020)
8.1.2 South America PET Radiopharmaceuticals Revenue and Market Share by Country (2015-2020)
8.2 Brazil PET Radiopharmaceuticals Sales and Growth Rate (2015-2020)
8.3 Argentina PET Radiopharmaceuticals Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa PET Radiopharmaceuticals Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa PET Radiopharmaceuticals Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa PET Radiopharmaceuticals Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia PET Radiopharmaceuticals Sales and Growth Rate (2015-2020)
9.3 Turkey PET Radiopharmaceuticals Sales and Growth Rate (2015-2020)
9.4 Egypt PET Radiopharmaceuticals Sales and Growth Rate (2015-2020)
9.5 South Africa PET Radiopharmaceuticals Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global PET Radiopharmaceuticals Sales and Market Share by Type (2015-2020)
10.2 Global PET Radiopharmaceuticals Revenue and Market Share by Type (2015-2020)
10.3 Global PET Radiopharmaceuticals Price by Type (2015-2020)
11 Global PET Radiopharmaceuticals Market Segment by Application
11.1 Global PET Radiopharmaceuticals Sales Market Share by Application (2015-2020)
11.2 Global PET Radiopharmaceuticals Revenue Market Share by Application (2015-2020)
11.3 Global PET Radiopharmaceuticals Price by Application (2015-2020)
12 Market Forecast
12.1 Global PET Radiopharmaceuticals Sales, Revenue and Growth Rate (2021-2025)
12.2 PET Radiopharmaceuticals Market Forecast by Regions (2021-2025)
12.2.1 North America PET Radiopharmaceuticals Market Forecast (2021-2025)
12.2.2 Europe PET Radiopharmaceuticals Market Forecast (2021-2025)
12.2.3 Asia-Pacific PET Radiopharmaceuticals Market Forecast (2021-2025)
12.2.4 South America PET Radiopharmaceuticals Market Forecast (2021-2025)
12.2.5 Middle East & Africa PET Radiopharmaceuticals Market Forecast (2021-2025)
12.3 PET Radiopharmaceuticals Market Forecast by Type (2021-2025)
12.3.1 Global PET Radiopharmaceuticals Sales Forecast by Type (2021-2025)
12.3.2 Global PET Radiopharmaceuticals Market Share Forecast by Type (2021-2025)
12.4 PET Radiopharmaceuticals Market Forecast by Application (2021-2025)
12.4.1 Global PET Radiopharmaceuticals Sales Forecast by Application (2021-2025)
12.4.2 Global PET Radiopharmaceuticals Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global PET Radiopharmaceuticals Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of PET Radiopharmaceuticals by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global PET Radiopharmaceuticals Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Cardinal Health Inc. (U.S.) Basic Information, Manufacturing Base and Competitors
Table 8. Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Major Business
Table 9. Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Total Revenue (USD Million) (2017-2018)
Table 10. Cardinal Health Inc. (U.S.) SWOT Analysis
Table 11. Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Product and Services
Table 12. Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Nordion, Inc. (Canada) Basic Information, Manufacturing Base and Competitors
Table 14. Nordion, Inc. (Canada) PET Radiopharmaceuticals Major Business
Table 15. Nordion, Inc. (Canada) PET Radiopharmaceuticals Total Revenue (USD Million) (2017-2018)
Table 16. Nordion, Inc. (Canada) SWOT Analysis
Table 17. Nordion, Inc. (Canada) PET Radiopharmaceuticals Product and Services
Table 18. Nordion, Inc. (Canada) PET Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Lantheus Medical Imaging, Inc. (U.S.) Basic Information, Manufacturing Base and Competitors
Table 20. Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Major Business
Table 21. Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Total Revenue (USD Million) (2017-2018)
Table 22. Lantheus Medical Imaging, Inc. (U.S.) SWOT Analysis
Table 23. Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Product and Services
Table 24. Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Mallinckrodt plc (Ireland) Basic Information, Manufacturing Base and Competitors
Table 26. Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Major Business
Table 27. Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Total Revenue (USD Million) (2017-2018)
Table 28. Mallinckrodt plc (Ireland) SWOT Analysis
Table 29. Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Product and Services
Table 30. Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Eczacibasi-Monrol Nuclear Products (Turkey) Basic Information, Manufacturing Base and Competitors
Table 32. Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Major Business
Table 33. Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Total Revenue (USD Million) (2017-2018)
Table 34. Eczacibasi-Monrol Nuclear Products (Turkey) SWOT Analysis
Table 35. Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Product and Services
Table 36. Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. GE Healthcare (U.K.) Basic Information, Manufacturing Base and Competitors
Table 38. GE Healthcare (U.K.) PET Radiopharmaceuticals Major Business
Table 39. GE Healthcare (U.K.) PET Radiopharmaceuticals Total Revenue (USD Million) (2017-2018)
Table 40. GE Healthcare (U.K.) SWOT Analysis
Table 41. GE Healthcare (U.K.) PET Radiopharmaceuticals Product and Services
Table 42. GE Healthcare (U.K.) PET Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. IBA Molecular Imaging (Belgium) Basic Information, Manufacturing Base and Competitors
Table 44. IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Major Business
Table 45. IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Total Revenue (USD Million) (2017-2018)
Table 46. IBA Molecular Imaging (Belgium) SWOT Analysis
Table 47. IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Product and Services
Table 48. IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Bracco Imaging S.p.A (Italy) Basic Information, Manufacturing Base and Competitors
Table 50. Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Major Business
Table 51. Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Total Revenue (USD Million) (2017-2018)
Table 52. Bracco Imaging S.p.A (Italy) SWOT Analysis
Table 53. Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Product and Services
Table 54. Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Bayer AG (Germany) Basic Information, Manufacturing Base and Competitors
Table 56. Bayer AG (Germany) PET Radiopharmaceuticals Major Business
Table 57. Bayer AG (Germany) PET Radiopharmaceuticals Total Revenue (USD Million) (2017-2018)
Table 58. Bayer AG (Germany) SWOT Analysis
Table 59. Bayer AG (Germany) PET Radiopharmaceuticals Product and Services
Table 60. Bayer AG (Germany) PET Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Advanced Accelerator Applications S.A. (France) Basic Information, Manufacturing Base and Competitors
Table 62. Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Major Business
Table 63. Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Total Revenue (USD Million) (2017-2018)
Table 64. Advanced Accelerator Applications S.A. (France) SWOT Analysis
Table 65. Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Product and Services
Table 66. Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Global PET Radiopharmaceuticals Sales by Manufacturer (2018-2019) (K Pcs)
Table 68. Global PET Radiopharmaceuticals Revenue by Manufacturer (2018-2019) (USD Million)
Table 69. Global PET Radiopharmaceuticals Sales by Regions (2015-2020) (K Pcs)
Table 70. Global PET Radiopharmaceuticals Sales Market Share by Regions (2015-2020)
Table 71. Global PET Radiopharmaceuticals Revenue by Regions (2015-2020) (USD Million)
Table 72. North America PET Radiopharmaceuticals Sales by Countries (2015-2020) (K Pcs)
Table 73. North America PET Radiopharmaceuticals Sales Market Share by Countries (2015-2020)
Table 74. North America PET Radiopharmaceuticals Revenue by Countries (2015-2020) (USD Million)
Table 75. North America PET Radiopharmaceuticals Revenue Market Share by Countries (2015-2020)
Table 76. Europe PET Radiopharmaceuticals Sales by Countries (2015-2020) (K Pcs)
Table 77. Europe PET Radiopharmaceuticals Sales Market Share by Countries (2015-2020)
Table 78. Europe PET Radiopharmaceuticals Revenue by Countries (2015-2020) (USD Million)
Table 79. Asia-Pacific PET Radiopharmaceuticals Sales by Regions (2015-2020) (K Pcs)
Table 80. Asia-Pacific PET Radiopharmaceuticals Sales Market Share by Regions (2015-2020)
Table 81. Asia-Pacific PET Radiopharmaceuticals Revenue by Regions (2015-2020) (USD Million)
Table 82. South America PET Radiopharmaceuticals Sales by Countries (2015-2020) (K Pcs)
Table 83. South America PET Radiopharmaceuticals Sales Market Share by Countries (2015-2020)
Table 84. South America PET Radiopharmaceuticals Revenue by Countries (2015-2020) (USD Million)
Table 85. South America PET Radiopharmaceuticals Revenue Market Share by Countries (2015-2020)
Table 86. Middle East & Africa PET Radiopharmaceuticals Sales by Countries (2015-2020) (K Pcs)
Table 87. Middle East & Africa PET Radiopharmaceuticals Sales Market Share by Countries (2015-2020)
Table 88. Middle East & Africa PET Radiopharmaceuticals Revenue by Countries (2015-2020) (USD Million)
Table 89. Middle East & Africa PET Radiopharmaceuticals Revenue Market Share by Countries (2015-2020)
Table 90. Global PET Radiopharmaceuticals Sales by Type (2015-2020) (K Pcs)
Table 91. Global PET Radiopharmaceuticals Sales Share by Type (2015-2020)
Table 92. Global PET Radiopharmaceuticals Revenue by Type (2015-2020) (USD Million)
Table 93. Global PET Radiopharmaceuticals Revenue Share by Type (2015-2020)
Table 94. Global PET Radiopharmaceuticals Sales by Application (2015-2020) (K Pcs)
Table 95. Global PET Radiopharmaceuticals Sales Share by Application (2015-2020)
Table 96. Global PET Radiopharmaceuticals Sales Forecast by Regions (2021-2025) (K Pcs)
Table 97. Global PET Radiopharmaceuticals Market Share Forecast by Regions (2021-2025)
Table 98. Global PET Radiopharmaceuticals Sales Forecast by Type (2021-2025) (K Pcs)
Table 99. Global PET Radiopharmaceuticals Market Share Forecast by Type (2021-2025)
Table 100. Global PET Radiopharmaceuticals Sales Forecast by Application (2021-2025)
Table 101. Global PET Radiopharmaceuticals Market Share Forecast by Application (2021-2025)
Table 102. Direct Channel Pros & Cons
Table 103. Indirect Channel Pros & Cons
Table 104. Distributors/Traders/ Dealers List
List of Figures
Figure 1. PET Radiopharmaceuticals Picture
Figure 2. Global Sales Market Share of PET Radiopharmaceuticals by Type in 2019
Figure 3. F-18 Picture
Figure 4. Ru-82 Picture
Figure 5. Others Picture
Figure 6. PET Radiopharmaceuticals Sales Market Share by Application in 2018
Figure 7. Oncology Picture
Figure 8. Cardiology Picture
Figure 9. Neurology Picture
Figure 10. Others Picture
Figure 11. Global PET Radiopharmaceuticals Market Status and Outlook (2015-2025) (USD Million)
Figure 12. United States PET Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Canada PET Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Mexico PET Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Germany PET Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 16. France PET Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 17. UK PET Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Russia PET Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Italy PET Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 20. China PET Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Japan PET Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Korea PET Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 23. India PET Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Southeast Asia PET Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Australia PET Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 26. Brazil PET Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Egypt PET Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Saudi Arabia PET Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 29. South Africa PET Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Turkey PET Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Global PET Radiopharmaceuticals Sales Market Share by Manufacturer in 2019
Figure 32. Global PET Radiopharmaceuticals Revenue Market Share by Manufacturer in 2019
Figure 33. Top 3 PET Radiopharmaceuticals Manufacturer (Revenue) Market Share in 2019
Figure 34. Top 6 PET Radiopharmaceuticals Manufacturer (Revenue) Market Share in 2019
Figure 35. Key Manufacturer Market Share Trend
Figure 36. Global PET Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Pcs)
Figure 37. Global PET Radiopharmaceuticals Revenue and Growth Rate (2015-2020) (USD Million)
Figure 38. Global PET Radiopharmaceuticals Revenue Market Share by Regions (2015-2020)
Figure 39. Global PET Radiopharmaceuticals Revenue Market Share by Regions in 2018
Figure 40. North America PET Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure 41. Europe PET Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure 42. Asia-Pacific PET Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure 43. South America PET Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure 44. Middle East & Africa PET Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure 45. North America PET Radiopharmaceuticals Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. North America PET Radiopharmaceuticals Sales Market Share by Countries (2015-2020)
Figure 47. North America PET Radiopharmaceuticals Sales Market Share by Countries in 2018
Figure 48. North America PET Radiopharmaceuticals Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 49. North America PET Radiopharmaceuticals Revenue Market Share by Countries in 2018
Figure 50. United States PET Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Pcs)
Figure 51. Canada PET Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Pcs)
Figure 52. Mexico PET Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Pcs)
Figure 53. Europe PET Radiopharmaceuticals Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. Europe PET Radiopharmaceuticals Revenue Market Share by Countries (2015-2020)
Figure 55. Europe PET Radiopharmaceuticals Revenue Market Share by Countries in 2019
Figure 56. Germany PET Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Pcs)
Figure 57. UK PET Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Pcs)
Figure 58. France PET Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Pcs)
Figure 59. Russia PET Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Pcs)
Figure 60. Italy PET Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Pcs)
Figure 61. Asia-Pacific PET Radiopharmaceuticals Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Asia-Pacific PET Radiopharmaceuticals Sales Market Share by Regions 2019
Figure 63. Asia-Pacific PET Radiopharmaceuticals Revenue Market Share by Regions 2019
Figure 64. China PET Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Pcs)
Figure 65. Japan PET Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Pcs)
Figure 66. Korea PET Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Pcs)
Figure 67. India PET Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Pcs)
Figure 68. Southeast Asia PET Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Pcs)
Figure 69. South America PET Radiopharmaceuticals Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. South America PET Radiopharmaceuticals Sales Market Share by Countries in 2019
Figure 71. South America PET Radiopharmaceuticals Revenue Market Share by Countries in 2019
Figure 72. Brazil PET Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Pcs)
Figure 73. Argentina PET Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Pcs)
Figure 74. Middle East and Africa PET Radiopharmaceuticals Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. Middle East and Africa PET Radiopharmaceuticals Sales Market Share by Countries in 2019
Figure 76. Middle East and Africa PET Radiopharmaceuticals Revenue Market Share by Countries (2015-2020)
Figure 77. Middle East and Africa PET Radiopharmaceuticals Revenue Market Share by Countries in 2019
Figure 78. Saudi Arabia PET Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Pcs)
Figure 79. Egypt PET Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Pcs)
Figure 80. Turkey PET Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Pcs)
Figure 81. South Africa PET Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Pcs)
Figure 82. Global PET Radiopharmaceuticals Sales and Growth Rate (2021-2025) (K Pcs)
Figure 83. Global PET Radiopharmaceuticals Revenue and Growth Rate (2021-2025) (USD Million)
Figure 84. North America Sales PET Radiopharmaceuticals Market Forecast (2021-2025) (K Pcs)
Figure 85. Europe Sales PET Radiopharmaceuticals Market Forecast (2021-2025) (K Pcs)
Figure 86. Asia-Pacific Sales PET Radiopharmaceuticals Market Forecast (2021-2025) (K Pcs)
Figure 87. South America Sales PET Radiopharmaceuticals Market Forecast (2021-2025) (K Pcs)
Figure 88. Middle East & Africa Sales PET Radiopharmaceuticals Market Forecast (2021-2025) (K Pcs)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel
診断用放射性医薬品・造影剤の世界市場（～2026年） Radiopharmaceuticals are a group of pharmaceutical drugs which have radioactivity. The contrast media plays an important role in enhancing the imaging facilities for better diagnosis. The market drivers are technology advancements in medical imaging, increasing demand for image guided procedures and…- PET放射性医薬品の世界市場（～2026年） Market Analysis and Insights: Global PET Radiopharmaceuticals Market The global PET Radiopharmaceuticals market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global PET Radiopharmaceuticals Scope and Market Size PET Radiopharmaceu…
- 中枢神経系（CNS）バイオマーカーの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Central Nervous System Biomarkers market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.6% in the forecast period of 2020 to 2025 and will expected to reach USD 4797.5 million by 2025, from USD 3851.7 million in 2019. The Ce…
- 心臓核医学の世界市場（～2026年） Nuclear imaging in cardiac disorders aids in accurate diagnosis of cardiovascular diseases and blockages in blood flow. Nuclear imaging is a technique for producing images of various body parts utilizing radioactive materials. This technique has applications in diagnosis of various cardiovascular di…
- 改修心臓血管及び心臓病用機器の世界市場（～2026年） Market Analysis and Insights: Global Refurbished Cardiovascular & Cardiology Equipment Market The global Refurbished Cardiovascular & Cardiology Equipment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Refurbished Car…